LEXAPRO escitalopram (as oxalate) 10mg tablet blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

lexapro escitalopram (as oxalate) 10mg tablet blister pack

lundbeck australia pty ltd - escitalopram oxalate, quantity: 12.77 mg (equivalent: escitalopram, qty 10 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; purified talc; titanium dioxide; hypromellose; purified water; macrogol 400 - treatment of major depression. treatment of social anxiety disorder (social phobia). treatment of generalised anxiety disorder. treatment of obsessive-compulsive disorder.

Keral 50 mg/2ml solution for injection/infusion Irland - engelsk - HPRA (Health Products Regulatory Authority)

keral 50 mg/2ml solution for injection/infusion

menarini international operations luxembourg s.a. - dexketoprofen trometamol - solution for injection/infusion - 50 mg/2ml - propionic acid derivatives; dexketoprofen

Keral 50mg/2ml  Solution for injection/infusion Malta - engelsk - Medicines Authority

keral 50mg/2ml solution for injection/infusion

menarini international operations luxembourg s.a 1 avenue de la gare, l-1611, luxembourg - dexketoprofen - solution for injection concentrate for solution for infusion - dexketoprofen 25 mg/ml - antiinflammatory and antirheumatic products

LEXAPRO- escitalopram oxalate tablet USA - engelsk - NLM (National Library of Medicine)

lexapro- escitalopram oxalate tablet

physicians total care, inc. - escitalopram oxalate (unii: 5u85dbw7lo) (escitalopram - unii:4o4s742any) - escitalopram oxalate 5 mg -   lexapro (escitalopram) is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age [see clinical studies (14.1) ]. a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. lexapro is indicated for the acute treatment of generalized anxiety disorder (gad) in adults [see clinical studies (14.2) ]. generalized anxiety disorder (dsm-iv) is characterized by excessive anxiety and worry (apprehensive expectation) that is persistent for at

LEXAPRO- escitalopram tablet USA - engelsk - NLM (National Library of Medicine)

lexapro- escitalopram tablet

direct rx - escitalopram oxalate (unii: 5u85dbw7lo) (escitalopram - unii:4o4s742any) - escitalopram 10 mg - 1.1 major depressive disorder escitalopram tablets usp are indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age [see clinical studies (14.1)]. a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. 1.2 generalized anxiety disorder escitalopram tablets are indicated for the acute treatment of generalized anxiety disorder (gad) in adults [see clinical studies (14.2)]. generalized anxiety disorder (dsm-iv) is characterized by excessive anxiety